A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2027, filed Oct 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the STZ SEC filings page.
Constellation Brands, Inc. (STZ) reported $9.2B in revenue over the twelve months to Aug 31, 2026, down 4.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Constellation’s earnings are volatile, but cash generation remains positive; the balance sheet carries leverage without severe short-term tightness.
FY2026 net income was$1.69B alongside operating cash flow of$2.67B , indicating cash conversion remains stronger than the headline earnings volatility suggests. Gross margin stayed roughly flat across FY2025-FY2026, while the operating margin rebound ran from3.5% to29.8% ; the earnings swing therefore occurred below gross profit rather than in the core gross spread.
FY2025 produced an accounting loss of
The balance sheet is neither lightly leveraged nor acutely constrained short term: debt-to-equity was 1.2x and the current ratio was 1.1x in FY2026. A financing outflow of
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Constellation Brands, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Constellation Brands, Inc. has an operating margin of 29.8%, meaning the company retains $30 of operating profit per $100 of revenue. This strong profitability earns a score of 78/100, reflecting efficient cost management and pricing power. This is up from 3.5% the prior year.
Constellation Brands, Inc.'s revenue declined 10.5% year-over-year, from $10.2B to $9.1B. This contraction results in a growth score of 18/100.
Constellation Brands, Inc. has elevated debt relative to equity (D/E of 1.20), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 20/100, reflecting increased financial risk.
Constellation Brands, Inc.'s current ratio of 1.08 is below the typical benchmark, resulting in a score of 23/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Constellation Brands, Inc. converts 19.6% of revenue into free cash flow ($1.8B). This strong cash generation earns a score of 84/100.
Constellation Brands, Inc. earns a strong 20.9% return on equity (ROE), meaning it generates $21 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 66/100. This is up from -1.2% the prior year.
Constellation Brands, Inc. scores 2.75, placing it in the grey zone between 1.81 and 2.99. The largest contribution to the score comes from a market capitalization of $23.5B against total liabilities of $13.5B. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Constellation Brands, Inc. passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Constellation Brands, Inc. generates $1.58 in operating cash flow ($2.7B OCF vs $1.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Constellation Brands, Inc. earns $7.53 in operating income for every $1 of interest expense ($2.7B vs $361.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Constellation Brands, Inc. generated $2.6B in revenue in Q2 2027. This represents an increase of 6.1% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.
Constellation Brands, Inc.'s EBITDA was $902.1M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 7.7% from the same quarter a year earlier. Against the prior quarter it is down 4.4%.
Constellation Brands, Inc. reported $565.8M in net income in Q2 2027. This represents an increase of 21.4% from the same quarter a year earlier. Against the prior quarter it is down 13.5%.
Not reported for Q2 2027.
Cash & Balance Sheet
Constellation Brands, Inc. generated $639.9M in free cash flow in Q2 2027, representing cash available after capex. This represents an increase of 0.8% from the same quarter a year earlier. Against the prior quarter it is up 32.0%.
Constellation Brands, Inc. held $98.5M in cash against $9.1B in long-term debt as of Q2 2027.
Not reported for Q2 2027.
Margins & Returns
Constellation Brands, Inc.'s gross margin was 52.9% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.
Constellation Brands, Inc.'s operating margin was 30.6% in Q2 2027, reflecting core business profitability. This is down 4.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.2 percentage points.
Constellation Brands, Inc.'s net profit margin was 21.5% in Q2 2027, showing the share of revenue converted to profit. This is up 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.4 percentage points.
Constellation Brands, Inc.'s quarterly ROE was 6.6% in Q2 2027: one quarter's net income over shareholder equity, not annualized. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.
Capital Allocation
Constellation Brands, Inc. spent $230.9M on share buybacks in Q2 2027, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 22.5% from the same quarter a year earlier. Against the prior quarter it is up 3.2%.
Constellation Brands, Inc. invested $176.9M in capex in Q2 2027, funding long-term assets and infrastructure. This represents a decrease of 18.6% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.
Not reported for Q2 2027.
STZ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6B+6.1% | $2.4B-3.3% | $1.9B-11.3% | $2.2B-9.8% | $2.5B-15.0% | $2.5B-5.5% | $2.2B+1.2% | $2.5B-0.3% |
| Cost of Revenue | $1.2B+5.9% | $1.1B-10.9% | N/A | $1.0B-11.9% | $1.2B-16.8% | $1.2B-0.8% | N/A | $1.2B-1.7% |
| Gross Profit | $1.4B+6.3% | $1.3B+4.3% | $951.7M-14.6% | $1.2B-7.9% | $1.3B-13.3% | $1.3B-9.8% | $1.1B+7.3% | $1.3B+1.1% |
| SG&A Expenses | $538.2M+23.4% | $457.0M-8.7% | N/A | $491.2M0.0% | $436.0M-11.2% | $500.7M+8.3% | N/A | $491.3M+3.7% |
| Operating Income | $805.0M-7.9% | $845.3M+18.4% | N/A | $692.0M-12.7% | $874.0Mn/m | $713.8M-24.2% | N/A | $793.0M-0.5% |
| EBITDA | $902.1M-7.7% | $943.2M+15.1% | N/A | $791.3M-13.3% | $977.1Mn/m | $819.3M-22.2% | N/A | $912.3M+0.8% |
| Interest Expense | $85.3M-4.2% | $87.7M-12.8% | N/A | $86.6M-19.6% | $89.0M-15.9% | $100.6M-4.0% | N/A | $107.7M+3.4% |
| Income Tax | $147.1M-50.4% | $88.1M+0.6% | N/A | $110.1M+147.4% | $296.8Mn/m | $87.6M+212.9% | N/A | $44.5M-65.8% |
| Net Income | $565.8M+21.4% | $653.8M+26.7% | $201.8Mn/m | $502.8M-18.4% | $466.0Mn/m | $516.1M-41.2% | -$375.3M-195.6% | $615.9M+21.0% |
Not reported in any period shown, so not listed: R&D Expenses, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
STZ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.1B+3.0% | $22.1B-0.7% | $21.9B+1.1% | $21.7B-4.9% | $21.4B-7.2% | $22.3B-14.6% | $21.7B-15.7% | $22.8B-9.0% |
| Current Assets | $3.0B+2.8% | $3.0B-22.8% | $2.9B-21.8% | $2.9B-19.8% | $2.9B-21.1% | $3.9B+2.9% | $3.7B-0.4% | $3.6B+2.2% |
| Cash & Equivalents | $98.5M+36.8% | $96.6M+30.7% | $102.4M+50.4% | $152.4M+106.8% | $72.0M+11.5% | $73.9M+0.1% | $68.1M-55.3% | $73.7M-6.4% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $1.4B-4.2% | $1.5B+2.9% | $1.4B-0.2% | $1.4B-35.2% | $1.4B-31.4% | $1.4B-33.6% | $1.4B-30.8% | $2.1B+7.1% |
| Long-Term Investments | $0-100.0% | $0-100.0% | $69.1M+14.6% | $61.7M-38.9% | $62.5M-30.9% | $67.7M-21.3% | $60.3M-17.4% | $100.9Mn/m |
| Goodwill | $5.3B+1.7% | $5.2B+1.8% | $5.2B+2.1% | $5.2B-7.5% | $5.2B-9.4% | $5.2B-35.4% | $5.1B-35.8% | $5.6B-29.7% |
| Total Liabilities | $13.2B-3.3% | $13.6B-8.0% | $13.5B-6.9% | $13.7B-7.1% | $13.6B-8.6% | $14.7B-4.9% | $14.5B-7.1% | $14.7B-3.4% |
| Current Liabilities | $3.0B+11.4% | $3.3B-9.9% | $2.7B-33.3% | $2.2B-33.9% | $2.7B-8.7% | $3.7B+18.3% | $4.0B+28.4% | $3.3B-2.7% |
| Non-Current Liabilities | $10.2B-6.9% | $10.2B-7.3% | $10.8B+3.3% | $11.5B+0.6% | $11.0B-8.6% | $11.0B-10.8% | $10.5B-16.0% | $11.4B-3.7% |
| Long-Term Debt | $9.1B-7.1% | $9.1B-7.1% | $9.7B+4.3% | $10.3B+1.0% | $9.8B-8.4% | $9.8B-8.4% | $9.3B-13.0% | $10.2B-0.9% |
| Total Equity | $8.6B+14.5% | $8.3B+13.6% | $8.1B+17.4% | $7.7B-1.4% | $7.5B-4.7% | $7.3B-29.1% | $6.9B-29.4% | $7.8B-17.5% |
| Retained Earnings | $14.4B+9.2% | $14.1B+8.6% | $13.6B+7.7% | $13.6B+3.0% | $13.2B+3.9% | $12.9B-8.3% | $12.6B-6.1% | $13.2B-0.2% |
Not reported in any period shown, so not listed: Accounts Receivable.
STZ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $816.8M-4.1% | $661.8M+3.9% | $562.8M-5.4% | $616.9M-10.0% | $852.1M-27.9% | $637.2M-7.7% | $594.7M+37.3% | $685.2M-5.5% |
| Depreciation & Amortization | $97.1M-5.8% | $97.9M-7.2% | $112.1M+5.6% | $99.3M-16.8% | $103.1M-5.9% | $105.5M-5.7% | $106.2M-0.2% | $119.3M+10.1% |
| Stock-Based Compensation | N/A | $15.0M+44.2% | N/A | N/A | N/A | $10.4M-39.9% | N/A | N/A |
| Capital Expenditures | $176.9M-18.6% | $177.2M-8.1% | $218.9M-22.5% | $246.0M+7.7% | $217.3M-33.7% | $192.8M-48.6% | $282.6M-20.9% | $228.4M-30.8% |
| Free Cash Flow | $639.9M+0.8% | $484.6M+9.0% | $343.9M+10.2% | $370.9M-18.8% | $634.8M-25.7% | $444.4M+41.0% | $312.1M+310.7% | $456.8M+15.7% |
| Investing Cash Flow | -$157.2M-123.8% | -$193.2Mn/m | -$213.6M-273.1% | -$234.7Mn/m | $660.9Mn/m | -$196.1Mn/m | $123.4Mn/m | -$240.6Mn/m |
| Financing Cash Flow | -$657.5Mn/m | -$474.0Mn/m | -$401.3Mn/m | -$301.6Mn/m | -$1.5Bn/m | -$437.6Mn/m | -$723.0Mn/m | -$434.8Mn/m |
| Dividends Paid | $176.0M-1.9% | $178.7M-1.9% | $176.9M-2.0% | $177.9M-3.0% | $179.4M-2.1% | $182.2M-1.7% | $180.5M+10.9% | $183.4M+11.7% |
| Share Buybacks | $230.9M-22.5% | $223.8M-26.9% | $100.0M-78.1% | $220.1M+0.5% | $297.9M+19.5% | $306.1M+53.0% | $455.7Mn/m | $218.9M+2.0% |
STZ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.9%+0.1pp | 54.3%+3.9pp | 49.6%-2.0pp | 53.2%+1.1pp | 52.8%+1.0pp | 50.4%-2.4pp | 51.5%+2.9pp | 52.1%+0.7pp |
| Operating Margin | 30.6%-4.7pp | 34.8%+6.4pp | N/A | 31.1%-1.1pp | 35.2%+77.4pp | 28.4%-7.0pp | N/A | 32.2%-0.1pp |
| Net Margin | 21.5%+2.7pp | 26.9%+6.4pp | 10.5%+27.8pp | 22.6%-2.4pp | 18.8%+59.9pp | 20.5%-12.4pp | -17.3%-35.7pp | 25.0%+4.4pp |
| Return on Equity | 6.6%+0.4pp | 7.9%+0.8pp | 2.5%+8.0pp | 6.5%-1.4pp | 6.2%+21.4pp | 7.1%-1.5pp | -5.5%-9.5pp | 7.9%+2.5pp |
| Return on Assets | 2.6%+0.4pp | 3.0%+0.6pp | 0.9%+2.6pp | 2.3%-0.4pp | 2.2%+7.4pp | 2.3%-1.1pp | -1.7%-3.3pp | 2.7%+0.7pp |
| Current Ratio | 1.00-0.1x | 0.91-0.2x | 1.08+0.2x | 1.34+0.2x | 1.08-0.2x | 1.07-0.2x | 0.92-0.3x | 1.10+0.1x |
| Debt-to-Equity | 1.06-0.2x | 1.10-0.2x | 1.20-0.2x | 1.330.0x | 1.30-0.1x | 1.35+0.3x | 1.35+0.3x | 1.30+0.2x |
| Liabilities-to-Equity | 1.54-0.3x | 1.64-0.4x | 1.67-0.4x | 1.77-0.1x | 1.82-0.1x | 2.03+0.5x | 2.11+0.5x | 1.88+0.3x |
| Asset Turnover | 0.120.0x | 0.110.0x | 0.090.0x | 0.100.0x | 0.120.0x | 0.110.0x | 0.100.0x | 0.110.0x |
| FCF Margin | 24.3%-1.3pp | 19.9%+2.2pp | 17.9%+3.5pp | 16.7%-1.9pp | 25.6%-3.7pp | 17.7%+5.8pp | 14.4%+10.9pp | 18.5%+2.6pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Constellation Brands, Inc. STZ | FY2026 | $9.1B | $1.7B | 18.5% | $23.5B | 48/100 |
| FOMENTO ECONOMICO MEXICANO, S.A.B. DE C.V. FMX | FY2025 | $46.7B | $1.8B | 3.9% | $44.0B | 63/100 |
| Anheuser-Busch InBev SA/NV BUD | FY2025 | $59.3B | $6.8B | 11.5% | $168.3B | 51/100 |
| Molson Coors Beverage Company TAP | FY2025 | $13.0B | -$2.1B | -16.4% | $7.8B | 32/100 |
| Boston Beer Company SAM | FY2025 | $2.0B | $108.5M | 5.5% | $2.0B | 54/100 |
Where Constellation Brands, Inc. Ranks
Frequently Asked Questions
What is Constellation Brands, Inc.'s annual revenue?
Constellation Brands, Inc. (STZ) reported $9.1B in total revenue for fiscal year 2026. This represents a -10.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Constellation Brands, Inc.'s revenue growing?
Constellation Brands, Inc. (STZ) revenue declined by 10.5% year-over-year, from $10.2B to $9.1B in fiscal year 2026.
Is Constellation Brands, Inc. profitable?
Yes, Constellation Brands, Inc. (STZ) reported a net income of $1.9B over the trailing 12 months to August 31, 2026. In fiscal year 2026 it reported a net income of $1.7B, with a net profit margin of 18.5%.
What is Constellation Brands, Inc.'s EBITDA?
Constellation Brands, Inc. (STZ) had EBITDA of $3.1B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Constellation Brands, Inc. have?
As of fiscal year 2026, Constellation Brands, Inc. (STZ) had $102.4M in cash and equivalents against $9.7B in long-term debt.
What is Constellation Brands, Inc.'s gross margin?
Constellation Brands, Inc. (STZ) had a gross margin of 51.5% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Constellation Brands, Inc.'s operating margin?
Constellation Brands, Inc. (STZ) had an operating margin of 29.8% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Constellation Brands, Inc.'s net profit margin?
Constellation Brands, Inc. (STZ) had a net profit margin of 18.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Constellation Brands, Inc.'s return on equity (ROE)?
Constellation Brands, Inc. (STZ) has a return on equity of 20.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Constellation Brands, Inc.'s free cash flow?
Constellation Brands, Inc. (STZ) generated $1.8B in free cash flow during fiscal year 2026. This represents a -7.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Constellation Brands, Inc.'s operating cash flow?
Constellation Brands, Inc. (STZ) generated $2.7B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Constellation Brands, Inc.'s total assets?
Constellation Brands, Inc. (STZ) had $21.9B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Constellation Brands, Inc.'s capital expenditures?
Constellation Brands, Inc. (STZ) invested $875.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Constellation Brands, Inc.'s current ratio?
Constellation Brands, Inc. (STZ) had a current ratio of 1.08 as of fiscal year 2026, which is considered adequate.
What is Constellation Brands, Inc.'s debt-to-equity ratio?
Constellation Brands, Inc. (STZ) had a debt-to-equity ratio of 1.20 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Constellation Brands, Inc.'s liabilities-to-equity ratio?
Constellation Brands, Inc. (STZ) had a liabilities-to-equity ratio of 1.67 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Constellation Brands, Inc.'s return on assets (ROA)?
Constellation Brands, Inc. (STZ) had a return on assets of 7.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Constellation Brands, Inc.'s P/E ratio?
Constellation Brands, Inc. (STZ) trades at 12.2x earnings, its market capitalization divided by $1.9B net income, trailing 12 months to August 31, 2026. The market capitalization is $23.5B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Constellation Brands, Inc.'s price-to-sales ratio?
Constellation Brands, Inc. (STZ) trades at 2.5x sales, its market capitalization divided by $9.2B revenue, trailing 12 months to August 31, 2026. The market capitalization is $23.5B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Constellation Brands, Inc.'s Altman Z-Score?
Constellation Brands, Inc. (STZ) has an Altman Z-Score of 2.75, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Constellation Brands, Inc.'s Piotroski F-Score?
Constellation Brands, Inc. (STZ) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Constellation Brands, Inc.'s earnings high quality?
Constellation Brands, Inc. (STZ) has an earnings quality ratio of 1.58x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Constellation Brands, Inc. cover its interest payments?
Constellation Brands, Inc. (STZ) has an interest coverage ratio of 7.53x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Constellation Brands, Inc.?
Constellation Brands, Inc. (STZ) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.